Latest Breaking News On - Frequent grade - Page 1 : vimarsana.com

Zentalis Announces Presentation of Positive Phase 1b Data

Strong anti-tumor activity shown in a platinum-resistant ovarian cancer population, with a confirmed ORR of 50.0% and mPFS of 7.4 months in combination.

San diegoUnited statesNew yorkKimberly blackwellPremalh thakerJoyce liuEmily whiteDanielle canteyDivision of gynecologic oncologyZentalis pharmaceuticalsGynecological oncology clinical researchDana farber cancer instituteWashington university school of medicineSolebury strategic communicationsExchange commissionPharmaceuticals inc

Zentalis Pharmaceuticals (ZNTL) Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy

Zentalis Pharmaceuticals (ZNTL) Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSan diegoJoyce liuPremalh thakerDanielle canteyevoke canaleKimberly blackwellPharmaceuticals incDana farber cancer instituteExchange commissionZentalis pharmaceuticalsEmily whitesolebury strategic communicationsDivision of gynecologic oncologyGynecological oncology clinical researchWashington university school of medicineChief executive officer